Donor cells battle Post-Transplant cancer in groundbreaking trial
NCT ID NCT00033475
Summary
This study tested whether adding specially prepared donor white blood cells to reduced anti-rejection medication works better than just reducing medication alone to treat a type of lymphoma that can occur after an organ transplant. It involved 50 patients who had developed this Epstein-Barr virus-linked cancer after receiving a heart, lung, liver, or kidney transplant. The goal was to see if the donor cells could help the patient's immune system fight the cancer more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOPROLIFERATIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Birmingham Children's Hospital
Birmingham, England, B4 6NH, United Kingdom
-
Central Manchester and Manchester Children's University Hospitals NHS Trust
Manchester, England, M27 4HA, United Kingdom
-
Institute of Cancer Research - UK
Sutton, England, SM2 5NG, United Kingdom
-
King's College Hospital
London, England, SE5 8RX, United Kingdom
-
Northern General Hospital
Sheffield, England, S5 7AU, United Kingdom
-
Papworth Hospital
Cambridge, England, CB3 8RE, United Kingdom
-
Royal Free and University College Medical School
London, England, NW3 2PF, United Kingdom
-
Royal Infirmary - Castle
Glasgow, Scotland, G4 0SF, United Kingdom
-
Royal Infirmary of Edinburgh at Little France
Edinburgh, Scotland, EH16 4SA, United Kingdom
-
University of Edinburgh
Edinburgh, Scotland, EH8 1QH, United Kingdom
-
University of Edinburgh Laboratory for Clinical and Molecular Virology
Edinburgh, Scotland, EH9 1QH, United Kingdom
-
Wythenshawe Hospital
Manchester, England, M23 9LJ, United Kingdom
Conditions
Explore the condition pages connected to this study.